Clinical accuracy, defined as the ability to discriminate between states of health, is the fundamental property of any diagnostic test or system. It is readily expressed as clinical sensitivity and specificity, and elegantly represented by the receiver operating characteristic (ROC) curve. To demonstrate the use of ROC curves, we reexamine a study of the ability of serum lipid and apolipoprotein measures to discriminate among degrees of coronary artery disease in patients undergoing coronary anglography. ROC curve analysis reveals that none of these indexes is highly accurate, but demonstrates a modest increase in the accuracy of apolipoprotein over lipid indexes. A current public health goal is to identify persons with coronary artery disease (CAD) that is advanced enough to warrant dietary modification, exercise, medication, coronary angioplasty, or coronary bypass surgery. An earlier report examined the use of blood lipid and lipoprotein concentrations to discriminate between subjects with and without significant CAD, as defined by angiography, using multiple logistic regression analysis (9). It concluded that apolipoprotein (apo) A-I and B gave more information for predicting CAD than did standard lipid determinations such as total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, or the ratio of HDL to total cholesterol.
Clinical accuracy, defined as the ability to discriminate between states of health, is the fundamental property of any diagnostic test or system. It is readily expressed as clinical sensitivity and specificity, and elegantly represented by the receiver operating characteristic (ROC) curve. To demonstrate the use of ROC curves, we reexamine a study of the ability of serum lipid and apolipoprotein measures to discriminate among degrees of coronary artery disease in patients undergoing coronary anglography. ROC curve analysis reveals that none of these indexes is highly accurate, but demonstrates a modest increase in the accuracy of apolipoprotein over lipid indexes. A current public health goal is to identify persons with coronary artery disease (CAD) that is advanced enough to warrant dietary modification, exercise, medication, coronary angioplasty, or coronary bypass surgery. An earlier report examined the use of blood lipid and lipoprotein concentrations to discriminate between subjects with and without significant CAD, as defined by angiography, using multiple logistic regression analysis (9). It concluded that apolipoprotein (apo) A-I and B gave more information for predicting CAD than did standard lipid determinations such as total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, or the ratio of HDL to total cholesterol.
We report a new analysis of the data, which is different in several ways from the report already published. We use ROC curve analysis to assess the diagnostic accuracy of each test. In addition to examining the power of each index to discriminate between no CAD and any CAD, we assess their use in discriminating between mild CAD and severe CAD. Finally, we divide the subjects by sex to see whether there are differences in accuracy. These analyses are not meant to suggest a particular clinical application or management strategy but to illustrate the use of ROC curve analysis in evaluating diagnostic performance at its most elementary level.
MaterIals and Methods
The 394 adult patients (272 males, 122 females) were evaluated by cardiac catheterization for symptoms of CAD or for valvular or congenital heart disease. Arteriograins were classified as follows: category 1, normal, luminni diameter of one or two major coronary branches or primary branches; and 4, severe, 50% obstruction of the luminal diameter of the left main coronary artery and (or) 70% narrowing of the diameter of all three major coronary arteries and (or) a major branch of all these vessels. Among the 394 subjects, 58 were classified as normal, and 336 had CAD in categories 2, 3, or 4 (any CAD). Among the 272 males, 33 were considered normal, and 239 had CAD. Of the 122 women, 25 were normal and 97 had CAD. Overall, there were 44 subjects with mild CAD and 111 with severe CAD. Among males only, there were 27 classified as mild and 86 classified as severe. The original study consisted of 504 subjects. However, those with any missing data were omitted from this study.
Serum total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, apo A-I, and apo B were determined as previously reported (9). The interassay precision was 1.7% at 6.6 mmol/L for total cholesterol, 2.7% at 1.2 mmol/L for HDL cholesterol, 4% at 3.0 mmol/L for triglycerides, 5.0% at 98 mg/dL for ape A-I, and 3.5% at 113 mg/dL for ape B. Three logistic models were studied. Model 1 used total cholesterol, the ratio of HDL to total cholesterol, age, smoking history, and sex. Model 2 used ape B, the ratio of ape B to apo A-I, age, smoking history, and sex. Model 3 used all four lipid indexes and the three covariates.
Discriminatory power (diagnostic accuracy) was assessed in two ways: the ability to distinguish no CAD from any CAD, and the ability to distinguish mild CAD from severe CAD. ROC curve analyses were performed by using a beta version of Rulemaker (Digital Medicine, Inc., Lebanon, NH), a program for the Macintosh personal computer. The ROC curve represents the full spectrum of possible sensitivity-specificity pairs (corresponding to all of the possible decision levels) for a test in a particular clinical application. The closer the ROC curve approaches the upper left corner, reflecting high sensitivity and a low false-positive rate (high specificity), the greater its accuracy. One useflil quantitative measure of accuracy is the area under the curve (1). The area of interest varies from 1.0, which corresponds to 1426 CLINICALCHEMISTRY, Vol.38, No.8, 1992 perfect discrimination, to 0.5, where no discrimination exists. Swets (1) suggests the following guidelines for interpretation of this area: 0.5-0.7, rather low accuracy; 0.7-0.9, accuracies useful for some purposes; and >0.9, rather high accuracy.
Results

ROC Areas
For discriminating no CAD from any CAD among all subjects, the areas under the ROC curves ranged from 0.59 to 0.77 (Table 1) , moderate accuracy by Swets's criteria. Model 3 has the highest area, as expected (becausemodels 2 and 1 are subsetsof model 3), but this is not statistically higher than the area for model 2. Models 2 and 3 have significantly larger areas (P <0.04 andP <0.02, respectively) than doesmodel 1, reflecting the superior discriminating ability of apolipoproteins over lipids. Furthermore, the area under the curve for ape B, the major protein constituent of LDL, is greater than that for either LDL cholesterol (P <0.02) or total cholesterol (P <0.02). The area for ape A-I, a major constituent of HDL, is slightly larger than the area for HDL cholesterol (not significant) and lower than th areas for the HDL-total cholesterol ratio, total chol terol, or LDL cholesterol. On the other hand, the are under the curve for the ratio of ape A-I to ape B i greater than that for total cholesterol (P <0.04), HD cholesterol (P <0.02), LDL cholesterol (P <0.04), or th ratio of HDL to total cholesterol (P <0.02). This su ports the conclusion that apolipoproteins offer som increase in discriminating ability over traditional lipi measures.
The database was further subdivided by sex to exam ine the accuracy of these indexes when applied solely one sex. In most cases, areas for one sex are similar too lower than, and only occasionally slightly higher than areas for both sexes taken together (Table 1) .
We also were interested in whether subjects with mil CAD had different lipid or apolipeprotein concentratio than did suljects with severe CAD. We generated R curves based on these two groups alone (excluding an jects with no or moderate CAD). The null hypothes would be as follows: Blood lipid or apolipeprotein concen trations in individuals with severe CAD are no differen than they are in individuals with mild CAD. In fact, w found that all indexes had rather poor accuracy in distinguishing subjects with mild CAD from those with severe CAD. The areas ranged from 0.46 to 0.57. None was significantly different from 0.50, which is the area corresponding to no discrimination. We separated males and looked again at mild vs. severe CAD. The areas were still not significantly different from 0.50. Thus, it appears that subjects with mild and with severe CAD share the same distributions for the indexes we eyRmined. The null hypothesis was not contradicted by the data.
ROC Curves
Examples of curves are shown in Figures 1 and 2 . Figure 1 (left panel) compares ape B and LDL cholesterol. The areas are significantly different, although the absolute difference is small (0.058). The ape B curve is superior in general, but at the decision levels (cutoff values) corresponding to 60% sensitivity, the two tests have identical specificity (false-positive rates). At that decision level, the two tests seem to perform the same. This illustrates the limitation of displaying test performance at one decision level, such as in a 2 x 2 table, in contrast to the ROC curve, which displays performance at all decision levels. Figure 1 (center panel) , which compares the ratio of ape A-I to ape B with the ratio of HDL to total cholesterol, illustrates the additional discrimination provided by the apolipoprotein ratio over the lipid indexes. Although the ratio of ape A-I to apo B is significantly more accurate, neither achieves high true-positive rates (high sensitivity) at the same time that it has low falsepositive rates (high specificity). Figure 1 (right panel) plots model 2 (which includes apolipoprotein indexes) and model 1 (which includes only lipid indexes). Model 2 has a significantly larger area than does model 1, again reflecting the increased discrim#{149}Lnating power when apelipoprotein data are included. Figure 2 shows the lack of separation between subects with severe CAD and those with mild CAD by the atio of ape A-I to ape B. This curve varies back and orth along the 45 #{176}line, which corresponds to an area of .5, indicating no discrimination.
Discussion
ROC analysis can graphically represent pure, inherent diagnostic accuracy. It provides the raw data needed both to make the first-level assessment of test performance and to incorporate the test into the process of decision analysis, whereby an optimal overall strategy for patient care can be derived. One can readily assess the ability of tests (or variables such as age or history) to discriminate between no CAD and any CAD, between mild and severe CAD, or between none plus mild and moderate plus severe disease. One could also explore the accuracy of each test in selected groups of patients. ROC curves could have been generated for any index by using any group that had an adequate number of subjects.
ROC analysis of these data indicates that all of these indexes (including the regression models that combine indexes) have low to moderate accuracy in identifring clinically important degrees of CAD in patients referred for angiography. Accuracy, as reflected in the areas under the ROC curves, was generally higher for apelipoproteins than for lipids. Note the values for ape B and the ratio of ape A-I to ape B in 
